E-LIB Suche - Ergebnisse für: Kapetanakis, Venediktos

1

Cost–effectiveness analysis for avelumab first-line mainten..:

Critchlow, Simone ; Bullement, Ash ; Crabb, Simon...
Future Oncology. 20 (2024) 8 - p. 459-470 , 2024

Link: https://doi.org/10.2217/..

2

Matching-Adjusted Indirect Comparison of Amivantamab vs Mob..:

Kim, Tae Min ; Girard, Nicolas ; Leighl, Natasha B...
Future Oncology. 20 (2024) 8 - p. 447-458 , 2024

Link: https://doi.org/10.2217/..

3

Descriptive analysis to assess seasonal patterns of COVID-1..:

Kyaw, Moe H ; Spinardi, Julia Regazzini ; Jagun, Oladayo...
BMJ Open. 14 (2024) 1 - p. e081019 , 2024

Link: https://doi.org/10.1136/..

4

POSTER: MPN-092 Indirect Treatment Comparisons of Momelotin..:

Masarova, Lucia ; Verstovsek, Srdan ; Palandri, Francesca...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S188 , 2023

Link: https://doi.org/10.1016/..

5

A cost‐effectiveness analysis of avelumab plus best support..:

Su, Po‐Jung ; Xiao, Ying ; Lin, Amy Y....
Cancer Reports. 6 (2023) 10 - p. , 2023

Link: https://doi.org/10.1002/..

6

P1057: INDIRECT TREATMENT COMPARISONS OF MOMELOTINIB VS PAC..:

Masarova, Lucia ; Verstovsek, Srdan ; Palandri, Francesca...
HemaSphere. 7 (2023) S3 - p. e1863563 , 2023

Link: https://doi.org/10.1097/..

7

MPN-092 Indirect Treatment Comparisons of Momelotinib vs Pa..:

Masarova, Lucia ; Verstovsek, Srdan ; Palandri, Francesca...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S381-S382 , 2023

Link: https://doi.org/10.1016/..

8

Analysis of overall survival in patients with acid sphingom..:

Kapetanakis, Venediktos ; Shukla, Pragya ; Fournier, Marie..
Molecular Genetics and Metabolism. 135 (2022) 2 - p. S64 , 2022

Link: https://doi.org/10.1016/..

9

Tafasitamab Plus Lenalidomide Versus 3 Rituximab-Based Trea..:

Cordoba, Raul ; Prawitz, Thibaud ; Westley, Tracy...
Advances in Therapy. 39 (2022) 6 - p. 2668-2687 , 2022

Link: https://doi.org/10.1007/..

10

Belantamab mafodotin for the treatment of relapsed/refracto..:

Nikolaou, Andreas ; Ambavane, Apoorva ; Shah, Anshul...
Expert Review of Hematology. 14 (2021) 12 - p. 1137-1145 , 2021

Link: https://doi.org/10.1080/..

11

How Assessment-Schedule Matching Limits Bias When Comparing..:

Kapetanakis, Venediktos ; Prawitz, Thibaud ; Schlichting, Michael...
Value in Health. 24 (2021) 8 - p. 1137-1144 , 2021

Link: https://doi.org/10.1016/..

12

DREAMM-2: Indirect Comparisons of Belantamab Mafodotin vs. ..:

Prawitz, Thibaud ; Popat, Rakesh ; Suvannasankha, Attaya...
Advances in Therapy. 38 (2021) 11 - p. 5501-5518 , 2021

Link: https://doi.org/10.1007/..

13

MM-209: Assessing Efficacy via Indirect Comparison of Singl..:

Suvannasankha, Attaya ; Kapetanakis, Venediktos ; Prawitz, Thibaud...
Clinical Lymphoma Myeloma and Leukemia. 20 (2020) - p. S300-S301 , 2020

Link: https://doi.org/10.1016/..

14

Assessment-Schedule Matching in Unanchored Indirect Treatme..:

Kapetanakis, Venediktos ; Prawitz, Thibaud ; Schlichting, Michael...
PharmacoEconomics. 37 (2019) 12 - p. 1537-1551 , 2019

Link: https://doi.org/10.1007/..

15

Determination of the most appropriate method for extrapolat..:

Tremblay, Gabriel ; Livings, Christopher ; Crowe, Lydia..
ClinicoEconomics and Outcomes Research. 8 (2016) - p. 323-333 , 2016

Link: https://doi.org/10.2147/..